Fasting serum triglyceride, cholesterol, HDL cholesterol, HDL 2 &3 cholesterol, fasting plasma glucose and insulin and haemoglobin AI were measured under standardised conditions in a group of laboratory volunteers. Intra-individual variation was calculated for each parameter from weekly measurements on at least eleven successive occassions, and the minimum change in each parameter that would be significant at the level P<O·05 was calculated.
Fasting serum triglyceride, cholesterol, HDL cholesterol, HDL 2 &3 cholesterol, fasting plasma glucose and insulin and haemoglobin AI were measured under standardised conditions in a group of laboratory volunteers. Intra-individual variation was calculated for each parameter from weekly measurements on at least eleven successive occassions, and the minimum change in each parameter that would be significant at the level P<O·05 was calculated.
A further study compared intra-individual variation in different test populations. Data from the group of laboratory volunteers were taken to represent intraindividual variation under standard test conditions with an informed test population and data from a group of regularly monitored out-patients undergoing drug therapy for hypercholesterolaemia were taken to represent intra-individual variation under standard conditions in a typical test population. A group of inpatients under strict dietary control provided information on variation under extreme standardisation of test conditions. Intra-individual variation was greatest for all parameters in the outpatient population. Extreme standardisation of test condition reduced intra-individual variation beyond that of the laboratory volunteers only in the case of serum triglyceride.
Concentration changes in blood constituents may be the most sensitive indicators of the presence of suspected disease or changes in the severity of known pathology. However, in following the progress of a single individual, interpretation of changes cannot be made solely with reference to associations previously demonstrated in large study groups; observed changes may simply reflect an individual's normal biological variation in the parameter considered. Therefore, in order to assess the significance of observed changes in a parameter, intra-individual variation in that parameter should be considered.
To obtain a measure of intra-individual variation in all patients encountered is clearly impossible and summary estimates have to be applied. Statistical models have been proposed for detecting trends and forecasting normal 618 continuity on the basis of relatively short series of measurements. I However, it may be necessary to assess the significance of changes between two single rneasurernents.i
In the first part of the present study, the minimum change which may be detected as significant at P<O·05 has been calculated in 10 laboratory volunteers from estimates of their individual variance in biochemical parameters related to lipid and carbohydrate metabolism including serum triglyceride, cholesterol, high density lipoprotein (HDL) cholesterol and the HDLcholesterol subfractions, HDL 2and HDL). The HD~cholesterol subfraction has been shown to correlate more strongly with cardiovascular risk than other parameters;' and its measurement is likely to playa significant role in clinical assessment of hyperlipidaemia and cardiovascular disease. Intra-individual vari-ation has also been studied in the two most commonly employed parameters for monitoring the treatment of diabetics; fasting plasma glucose and haemoglobin Al (HbA 1 ) . Variation in fasting plasma insulin has also been measured.
In the second part of the study intraindividual variation in different populations tested under different conditions is examined. A further two groups are included in addition to the group considered in the first part of the study. A group of out-patients tested under identical conditions to the laboratory volunteers enables comparison of variation between two different test populations. A group of in-patients undergoing treatment with a strictly monitored diet provides information on intraindividual variation under extreme standardisation of test conditions. Variations in fasting plasma glucose and lipid parameters are considered in these between-group comparisons.
Subjects and methods
Fasting serum triglyceride, cholesterol, HDL cholesterol, HDL subfraction cholesterol, plasma glucose (FPG), insulin and haemoglobin AI (HbA 1 ) were measured in 10 individuals (six men, four women). Between 11 and 27 samples were taken from each subject at weekly intervals. Subjects were laboratory volunteers, familiar with the procedures involved, and were tested in the morning between 0900 hand 1030 h after an overnight fast commencing at 2100 h the previous evening. No other dietary restriction was applied. Procedures involved were standard techniques previously passed by the Hospital Ethical Committee for use with research volunteers.
The subject was rested semi-recumbent for 30 min to minimise stress and standardise for the effect of posture on serum cholesterol and lipoproteins." Thirty mL of blood was taken, without stasis, from an antecubital vein, 20 mL in to plain plastic tubes for estimation of serum lipids, 7 mL in to a lithium heparin containing tube for plasma estimations and 3 mL in to an EDTA containing tube for measurement of HbA I.
Blood for serum estimations was left for I h before separation to allow clot retraction. Blood for plasma estimations was placed on ice immediately and separated within 40 min. Serum, plasma and blood samples were stored at 4°C. Plasma glucose was measured on the day of sampling; serum lipids, lipoproteins and HbA I were analysed within 4 days; and plasma Intra-individual variation 619 for estimation of insulin was frozen at -20°C and stored for analysis in a single batch on completion of the study. Previous work in this laboratory suggests that insulin in these samples would be stable over the period of the study. Furthermore, no time trend was observed in the fasting insulin measurements, as would be expected if deterioration had been occurring.
Serum lipids and plasma glucose were measured by continuous flow methods as follows: serum cholesterol by Trinder's cholesterol . oxidase method (Boehringer-Mannheim, product no 148393), serum triglyceride by enzymatic hydrolysis followed by NADH-linked enzymatic determination of glycerol, (Boehringer-Mannheim, product no 166448) and glucose by Trinder's glucose oxidase method." HDL was measured as HDL cholesterol following heparin/manganese precipitation of other lipoprotein fractions." The HDL subfractions were measured by the dextran precipitation procedure of Gidez et al. ' According to this method HDL z in an HDLcontaining heparin-manganese supernatant is precipitated with dextran sulphate. HDL 3 cholesterol is estimated in the dextran supernatant and the HDL z cholesterol concentration then derived from the difference between the total HDL and HDL 3 cholesterol. In a study from this laboratory, HDL z concentrations derived according to this method correlate well with the reference preparative ultracentrifuge method." Plasma insulin was measured by a disequilibrium modification of the radioimmunoassay procedure of Ekins et al," with addition of labelled insulin after a 48-h pre-incubation with antibody. HbA I was estimated using commercially supplied ion-exchange microcolumns (Bio-Rad Laboratories Ltd, Watford, Herts, UK). A continuous estimate of within-and betweenbatch precision of the methods was made using the scheme of Rodbard.!'' Means, standard deviations (SD) and coefficients of variation (CV) were calculated for each parameter from each individual over the period of study and an average of all individual CVs taken for each parameter. Intrinsic intraindividual variation, excluding that due to methodological variation, was calculated from the difference between the total intra-individual variance and the between-batch method variance for each parameter. Intrinsic individual CVs were calculated and an average taken.
The minimum change in each parameter for a significance of P<0·05 to be assigned to that change was calculated for each individual according to the following requirernentr'
where Dm=minimum change; Si=total intraindividual standard deviation; S9~u/u=the 95% critical value derived from normal probability integral tables (1·96x2=2·77).
Intra-individual variation in a parameter may correlate with the prevailing concentration of that parameter and regression analysis of D m on mean concentration was performed. Where a significant correlation was found, D m was expressed as a function of the mean.
Data from 10 patients (five men, five women) participating in a clinical trial, approved by the Ethical Committee, for treatment of hypercholesterolaemia with a fibric acid preparation were analysed for intra-individual variation using the statistical procedure described below. The subjects in this group were tested as out-patients according to the protocol described above for the volunteer group. Fasting plasma glucose, serum triglyceride, cholesterol, HDL and HDL subfraction cholesterol were measured. Tests were carried out after one month of treatment and then monthly over 10-14 weeks. This group is subsequently referred to as the outpatient group.
Data from a group of 10 patients (six men, four women) undergoing a strict, long-term dietary regime for weight reduction were also analysed. The subjects were in-patients in the hospital Metabolic Ward and sampling was carried out according to the protocol described above for the laboratory volunteers (subsequently referred to as the volunteer group). Results were taken from measurements made in the patients' continuing clinical assessment. Concentrations of fasting plasma glucose, serum triglyceride, cholesterol and HDL were measured. Patients were receiving no drugs and were maintained on a 600 Kcal weight-reducing diet. Four diets were used and these varied in their carbohydrate and lipid content. Six patients received changes in diet during the course of the study but no variation could be detected with these changes. Data were analysed after patients had been dieting for between 12 and 15 days and tests were carried out twice weekly over 7-14 weeks. This group is subsequently referred to as the inpatient group.
In contrast to the volunteer group, intraindividual variation in both our out-and inpatient groups would be expected to include a component of variation due to the treatment being received. This variation will be timedependent. To make a valid comparison of intra-individual variation between the three groups, a time-independent measure of intraindividual variation for each parameter in each of the groups was derived from calculation of the standardised residual sum of squares at each test interval following regression analysis of each parameter on time for each subject. Intra-individual variation was then expressed as the standard deviation of the standardised residual sum of squares. Calculations were performed as follows:
dy.x=residual sum of squares of parameter value y at time x following regression of yon x. calculated as:
dy.x=y-(bx+c)
where b=slope of regression line; c=intercept of regression line. In order to enable a valid comparison between residuals derived from different populations it is necessary to standardise to a common variance. To this end the residual sums of squares is expressed as a proportion of the error residual mean square. The standard deviations of SRSS for each parameter for each individual were calculated and taken as a measure of the variation for that individual independent of time. SD SR SS for each parameter was then derived from the combined individual SRSS.
Results
Individual means and SDs, the overall method CV, average intrinsic individual CV, and average total individual CV for each parameter for the volunteer group are given in Table 1 . Individual Dms, average D m and D m as a percentage of the overall mean, are given in Table 2 . The correlation between each subject's D m and mean for each parameter is also given. None of the subjects reported any change in weight, diet or medication during the course of the study. Nevertheless, some parameters were found to correlate with time. This was particularly true of HbA 1 , the level of which showed a significant decrease with time in four of the ten cases studied. This might suggest some methodological variation since no concurrent change in FPG was found. However, the other HbA 1 studies, carried out concommitantly, showed no such variation. The volunteer group included one individual who proved to be hypertriglyceridaemic. Exclusion of this individual's LA  0·033  0·281  0·081  0·084  0·286  LB  0·028  0·135  0·066  0·095  0·279  LC  0·055  0·192  0·067  0·084  0·220  LD  0·067  0·205  0·075  0·097  0·283  LE  0·067  0·122  0·073  0·102  0·155  LF  0·062  0·279  0·091  0·087  0·237  LG  0·032  0·113  0·086  0·084  0·476  LH  0·037  0·166  0·090  0·097  0·167  LI  0·032  0·163  0·066  0·043  0·111  IJ  0·035  0·121  0·120  0·069  0·147  Overall mean  0·045  0·178  0·082  0·084  0·236 results from the analysis resulted in a Dill for triglyceride of 0·39 mmol/L. Results for the second part of the study are given in Table 3 (a--e). The SD sHss for all parameters in the outpatient group was higher than in the other two groups. There was little difference between the inpatient and volunteer group parameters with the exception of triglyceride which showed a lower SD sRss in the inpatient group.
The high SD sRss observed in the outpatient group could reflect their pathological state. All patients in this group were under treatment for hyperlipidaemia and a correlation was found between the overall SD sHss for each patient and the prevailing cholesterol concentration. Thus the high intra-individual variation for cholesterol in the outpatient group may well reflect the high cholesterol concentrations encountered in that group. The relatively high variation in FPG may also have been due to pathologically high levels seen in one diabetic patient whose SD sRss for FPG was the highest encountered. However, when this patient's results were excluded from the analysis the overall mean SD sHss for FPG in the outpatient group was still the highest observed. In contrast, although six of the ten patients in the drug group were hypertriglyceridaemic and one severely so (mean concentration 5·25 mmol/L), there was no relationship between each individual's SD sHss for triglyceride and prevailing triglyceride concentrations.
Discussion
The first part of the study suggests that substantial changes relative to mean levels are necessary for a significant change to be inferred. Support for the findings reported here comes from several previous studies.f '"!" Also, the variation in FPG reported above successfully predicts the results of a study carried out in this laboratory (unpublished data) of the difference between two FPG measurements from individuals tested at intervals of between 1 and 16 days with no known changes in treatment or habit intervening. 485 women were included in this study and it was found that 93·X% of subjects showed a difference of <0·56 mmol/L. Table 2 , data from the volunteer group predict that 95% of all changes in FPG will be <0·62 mmol/L.
As shown in
It is therefore important, if serial testing is to be effective, to consider ways in which intraindividual variation may be reduced. The total
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intra-individual variation reported here includes analytical variation. However, if this is taken into account then, as shown in Table 1 , variation is little altered for all parameters except HbA I and fasting insulin.
Intrinsic intra-individual variation will include variation relating to the test conditions and population. Outpatients or lay volunteers might show increased intra-individual variance when compared with laboratory workers who may be more aware of the importance of following a standard protocol for follow-up testing. In the second part of this study three groups were selected to provide a range of anticipated intra-individual variation. The outpatients showed the greatest variation in all parameters studied although the sampling interval in this group was' a month compared with twice weekly and weekly in the outpatient and volunteer groups. However, the study of Demacker et al., 11 showed no difference in variation with sampling interval. Intra-individual variation was therefore highest in the group in which least strict control would be expected and lowest in the most strictly controlled. The results suggest that triglyceride levels are particularly sensitive to stringency of est conditions. FPG also showed increased variation in the outpatient group compared with the two other groups. However, intra-individual variation in FPG in the strictly controlled inpatient group was slightly higher than in the volunteer group. The SD sRss for parameters in the inpatient and volunteer groups are strikingly similar and indicate that increasing the stringency of test conditions beyond those used as standard in this laboratory is unlikely to have a significant effect on intra-individual variation and, hence, on the power of the measurement to monitor significant changes. Only triglyceride appears to respond consistently to greater control of test conditions.
In conclusion, strict control of test conditions provides no reduction in intra-individual variation beyond that obtainable under the conditions laid down for sampling described above. However, under these conditions, intraindividual variation is relatively high. Therefore, where possible, such information should be gained from analysis of an overall trend in a series of measurements. This will be particularly true of HDL 2 cholesterol which, though a highly sensitive discriminator of cardiovascular risk in comparing large group, shows considerable variation when considered in a single individual.
